Concepedia

Yeonghak Bang

YB

8

Publications

259

Citations

8

H-Index

2020

Active since

Affiliations

University of Ulsan(Current)

Ulsan College

Asan Medical Center

Vita-Salute San Raffaele University

Istituto Oncologico Veneto

Yeonghak Bang is an author at University of Ulsan specializing in hepatology, pharmacotherapy, and cancer therapeutics.

Top concepts

Publications per year

2020–2021

8

Publications

8

Lenvatinib versus sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis

Andrea Casadei‐Gardini, Mario Scartozzi, Toshifumi Tada et al. · Liver International · 2021 · 60 citations

Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis

Jaekyung Cheon, Hong Jae Chon, Yeonghak Bang et al. · Liver Cancer · 2020 · 53 citations · Full text

Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study

Hyung‐Don Kim, Yeonghak Bang, Myung Ah Lee et al. · Liver International · 2020 · 46 citations

Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events

Changhoon Yoo, Seonggyu Byeon, Yeonghak Bang et al. · Liver International · 2020 · 44 citations

Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis

Andrea Casadei‐Gardini, Lorenza Rimassa, Margherita Rimini et al. · Journal of Cancer Research and Clinical Oncology · 2021 · 18 citations · Full text

, , +10

Rows per page

1–5 of 8